Centaurus Financial, Inc. Novo Nordisk A S Transaction History
Centaurus Financial, Inc.
- $1.43 Billion
- Q1 2025
A detailed history of Centaurus Financial, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Centaurus Financial, Inc. holds 10,149 shares of NVO stock, worth $703,528. This represents 0.05% of its overall portfolio holdings.
Number of Shares
10,149
Previous 9,355
8.49%
Holding current value
$703,528
Previous $804,000
12.44%
% of portfolio
0.05%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding NVO
# of Institutions
1,767Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.3 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.03 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$859 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$854 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$823 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $156B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...